Daiwa Securities Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-775
Closed -$1.13M 1183
2017
Q4
$1.13M Hold
775
0.01% 478
2017
Q3
$1.22M Hold
775
0.01% 420
2017
Q2
$1M Hold
775
0.01% 445
2017
Q1
$1.2M Buy
+775
New +$62.1K 0.01% 424

Other funds holding LLY

Daiwa Securities Group's LLY Position: Q1 2026 in Review

Daiwa Securities Group increased its Eli Lilly (LLY) stake by 9.4% in Q1 2026, buying an estimated $13.1M and bringing the position to 150,533 shares worth $138M. The position accounts for 0.4% of the portfolio, ranked #45.

Daiwa Securities Group first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $148M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Daiwa Securities Group held 150,533 shares of Eli Lilly worth $138M as of Q1 2026.
  • Daiwa Securities Group bought 12,875 Eli Lilly shares in Q1 2026, an estimated $13.1M.
  • Eli Lilly made up 0.4% of Daiwa Securities Group's portfolio in Q1 2026, its #45 holding.
  • Daiwa Securities Group first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • Daiwa Securities Group's Eli Lilly position peaked at $148M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.